AllDocs -> cancers

From the Library of the Men’s Health Network www.menshealthnetwork.org Center News: Newsletter: Volume 1, Issue 1 (August 2003) Study Confirms PSA Test Reduces Prostate Cancer Deaths in Blacks and Whites Patterns of incidence, survival, and mortality support the contention that increased PSA testing has resulted in earlier detection of prostate cancer , thus reducing the prostate cancer death rate in both black men and white men in the U.S., according to a new study. Cancer statistics support the notion that PSA testing locates cancer in the prostate before it has a chance to metastasize, or migrate, to other locations in the body where it leads to fatal tumors. PSA blood tests detect increased levels of a substance called prostate - specific antigen (PSA) that are a warning of possible prostate disease. Prostate cancer can be cured, if diagnosed ...

Scientific summary Prostate cancer care: improving measures of the patient experience Lead researcher: Professor Richard Baker, University of Leicester Aim To develop valid, reliable and usable measures of patient experience of prostate cancer care suitable for use in routine practice. Design 1. Interview and questionnaire survey of CSCs to establish their requirements for the measure(s) 2. Review of literature on patients’ experiences of prostate cancer care 3. Qualitative study of patients’ experiences of prostate cancer care 4. Development of a new measure from the NCPS questionnaire 5. Consensus study of the completeness of the new measure(s) 6. Question reduction through sequential pilots and elimination of redundant questions 7. Submission of the draft measure(s) to a sample of 400 patients of four CSCs to assess reliability, validity ...

prostate cancer Prostate Cancer In Texas 2002 Presented By: The Texas Cancer Registry The following PowerPoint presentation was created from Prostate Cancer in Texas 2002, published by the Texas Cancer Registry, a division of the Texas Department of Health. Highlights of the report are presented, as well as all tables and graphs. Incidence data are presented for Texas residents diagnosed with malignant prostate cancer for the years 1995-1998. Mortality data are presented for Texas residents who died of prostate cancer , from 1990-1999. Prostate Cancer : A Major Health Issue In Texas The most common type of invasive cancer diagnosed in men An estimated 11,607 new cases for 2002 The second leading cause of cancer death in men, exceeded only by lung cancer Since 1990, an average of 1,881 deaths each year from ...

RTOG P0011: Phase III Randomized Trial of RTOG P0011: Phase III Randomized Trial of Adjuvant Therapy for High Risk pT2/3N0 Adjuvant Therapy for High Risk pT2/3N0 Prostate Cancer Patients Prostate Cancer Patients PI: Richard PI: Richard Valicenti Valicenti , M.D. , M.D. Thomas Jefferson University Thomas Jefferson University Email: Email: richard richard . . valicenti valicenti @mail. @mail. tju tju . . edu edu Phone: 215 955 Phone: 215 955 - - 5936 5936 Page 2 Issues Issues Surveillance with PSA before initiating treatment Surveillance with PSA before initiating treatment • • Long Long - - term results are poor (durable control: 20 to 40%) term results are poor (durable ...

There are few moments more traumatic in a man's life, than when he hears his physician say, “You have prostate cancer .” Yet for over 180,000 American men 11,800 in New York alone this shattering diagnosis becomes a life preserving challenge. Fortunately, great strides have been made in the diagnosis and treatment of this malignancy. The regular testing of PSA ( prostate specific antigen) levels for men age 50 and over (age 40+ for African American men) has improved the likelihood of an early diagnosis, and therefore successful treatment. Heightened awareness of the subtle symptoms of prostate cancer , such as blood in the urine, difficulty urinating, weight loss, bone pain and anemia, has also encouraged men to seek their physician's care while still in early stages. Prostate patients today have more treatment options available than ever before. Technological advances, particularly in the use of radiation ...

prostate cancer Prostate cancer screening Blanka Divisova, R1 Epidemiology Prostate ca= 2nd leading cause of ca-related death among men in the US 2002: estimated 189,000 new cases 30,000 deaths Many tumors are only histologically evident, never develop clinically significant disease Epidemiology cont. Over the lifetime, 15% of US men will be diagnosed with prostate ca, 75% of these will be > 65 yo A man in the US has a 3% chance of dying from it For every pt who dies from prostate ca, at least 380 others will have prostate ca that cannot be detected clinically Incidence of prostate ca Accuracy of Screening Tests Meta-analysis of PSA and DRE OVID database search 1966-1999 13 articles Asymptomatic men >50 yo Abnormal finding on PSA or DRE: chance of ...

BOARD DECLARES SEPTEMBER 2001 AS PROSTATE CANCER AWARENESS MONTH September 24, 2001 For Immediate Release Christiansburg, Virginia – At its September 10 meeting, the Montgomery County Board of Supervisors unanimously proclaimed September as Prostate Cancer Awareness Month in Montgomery County. The Board’s resolution “urge(d) all men in Montgomery County to become aware of their own risks of prostate cancer , talk to their health care providers about prostate cancer , get screened for the disease whenever appropriate, and encourage all residents to become involved in the war on prostate cancer through this County’s education and advocacy initiatives.” The Board recognized further that : • In 2001 approximately 198,000 men in the United States will learn they have prostate cancer , and across the nation, prostate ...

PROSTATE CANCER 361 CHAPTER 17 Prostate cancer Kenneth J. Pienta, MD , Howard Sandler, MD , Javid Javidan, MD , and Martin G. Sanda, MD Prostate cancer is the most common cancer in US men. Despite the fact that this cancer will be diagnosed in an estimated 220,900 US men in the year 2003 and will lead to the death of over 28,900 men, there is no universally agreed- upon strategic plan for its diagnosis and management. Epidemiology Age The risk of developing prostate cancer begins to increase at age 50 years in white men who have no family history of the disease and at age 40 years in black men and those who have a first-degree relative (father, brother) with prostate cancer . Risk increases with age but, unlike other cancers, prostate can- cer has ...

European Urology European Urology 43 (2003) 337–341 RecentTrends in Prostate Cancer Incidence and Mortality in Southeast England Helen S. Evans a ,* , Henrik Møller a,b a Thames Cancer Registry, Division of Medicine, Guy’s, King’s and St. Thomas’ School of Medicine, 1st Floor, Capital House, 42 Weston Street, London SE1 3QD, UK b Cancer and Public Health Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK Accepted 28 January 2003 Abstract Objective: To investigate recent trends in prostate cancer incidence and mortality, with particular reference to changes in diagnostic techniques and treatment. Methods: The Thames Cancer Registry was used to identify all men, resident in SE England, diagnosed with prostate cancer between 1990 and 1999. Information ...

prostate cancer By 2nd Lt. Michael Chillstrom, 59th Medical Wing public affairs [766 words] Air Force?s Wilford Hall at forefront of prostate cancer battle Leading the way in medical research, Wilford Hall Medical Center was intricately involved in a highly publicized, landmark study on the drug Finasteride?s (Proscar) ability to prevent prostate cancer . Wilford Hall was the largest site?providing roughly 10 percent of the participant population?for this extensive seven-year, nationwide study, named the Prostate Cancer Prevention Trial, or PCPT. The trial, published in the July 17 edition of ?The New England Journal of Medicine,? found a 25 percent reduction in prostate cancer occurrences for healthy males taking Finasteride. Although the findings are far short of being a cure-all answer, physicians laud the trial?s ...

P R O S T A T E - H E L P , P R O S T A T E C A N C E R S T U D I E S Prostate Cancer Studies Their Reading, Adjusting and Understanding Page 2 P R O S T A T E - H E L P , P R O S T A T E C A N C E R S T U D I E S Written and published by: Don Cooley 20200 Via Santa Teresa San Jose, CA 95120-1105 Phone: 408-268-6400 Fax: 408-268-3300 Email: cooleydd@pacbell.net Web: http://www.cooleyville.com/ cancer Copyright by Don Cooley 2002 All rights reserved. No copy of this paper may be published in any form or by any means without the prior written permission of the publisher except where it is to be used on in mailing lists and discussion groups owned by me. January 9, 2002 Thanks to the following people who helped me greatly on the organizing, and correction of this paper. ...

1 1 I NVESTIGATION OF M ETASTATIC B ONE D ISEASE IN N EWLY D IAGNOSED P ROSTATE C ANCER U SING N UCLEAR M EDICINE T ECHNIQUES I NVESTIGATION OF M ETASTATIC B ONE D ISEASE IN N EWLY D IAGNOSED P ROSTATE C ANCER U SING N UCLEAR M EDICINE T ECHNIQUES Reviewed 2003 Scope This guidelines refers to the investigation of the presence of metastatic bone disease in newly diagnosed prostate cancer using nuclear medicine bone scans. It does not address the use of bone scans in patients already diagnosed with ...

Prostate Cancer 51 Cancer in Oregon, 2000 F. Prostate Cancer Age is the most important risk factor for prostate cancer with 65% of the diagnoses in men over age 65. While screening and treatment of prostate cancer are available, the costs (in adverse side affects such as incontinence and impotence) versus benefits are still questionable. Currently there is no consensus for public health policy regarding prostate cancer screening except to encourage men to discuss their options with their health care providers. Prostate cancer is the most common cancer diagnosed and the second leading cause of cancer -related deaths among men. Prostate cancer is the leading cancer incidence site for all race/ethnic groups except American Indians/Alaskan Natives. A brief overview of Oregon’s ...

Prostate Cancer Statistics UNITED STATES 220,900 28,900 168.9 33.9 Alabama 4,700 600 93.1 41.9 5 Alaska 200 † 152.2 22.6 Arizona 4,300 600 — 29.9 Arkansas 2,600 300 130.5 37.4 California 20,500 1 2,700 1 154.3 29.3 Colorado 2,600 300 156.9 30.8 Connecticut 2,800 400 165.6 31.0 Delaware 600 100 172.5 10 38.8 9 District of Columbia 600 100 256.6 1 53.7 1 Florida 15,800 2 2,100 2 — 30.1 Georgia 5,700 700 130.1 41.6 6 Hawaii 900 100 124.1 22.7 Idaho 1,100 100 ...

PUBLIC HEALTH FACT SHEET Prostate Cancer What is Prostate Cancer ? The prostate is a walnut sized gland located under the bladder at the base of the penis that surrounds the urethra. Prostate cancer is the overgrowth of prostate cells that form a tumor. What are the Symptoms of Prostate Cancer ? · Frequent urination · Trouble starting or holding back urine · Weak or interrupted urine flow · Pain or burning during urination · Inability to urinate · Blood in urine or semen · Pain on ejaculation · Frequent pain or stiffness in the lower back, hips, or upper thighs What are the Risk Factors for Prostate Cancer ? · Age · African-American ethnicity · Family history · Possible risk with diet that is low in fiber and high in fat How is Prostate Cancer Detected? · Prostate -specific ...

PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATIONP ATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATION PATIENT INFORMATIONP ATIENT INFORMATION PATIENT PATIENT INFORMATION Prostate cancer A collectable guide for you to use with your patients What is prostate cancer ? The prostate is a gland about the size of a chestnut. It lies at the base of the bladder, wrapped around the urethra – the tube that carries urine from the bladder out of the body (see above). The healthy prostate produces fluid that is added to semen to improve the motility of the sperm. ...

Version 2.0, 2002 Copyright © 2001 American Academy of Family Physicians. Permission is granted to reproduce this material for nonprofit educational uses. Written permission is required for all other uses, including electronic uses. The PSA & Prostate Cancer Physician’s At-a-Glance Resource Guide T T h h e e P P S S A A T T e e s s t t A A P P a a t t i i e e n n t t - - D D o o c c t t o o r r S S h h a a r r e e d d D D e e c c i i s s i i o o n n Many doctors and patients choose to screen for prostate cancer because they feel they should know whether or not there is an early cancer . In fact, screening is highly controversial because we still do not know if screening with a PSA or a digital rectal exam improves cancer outcomes, but we know that the treatment ...

R adical prostatectomy, radiation therapy, and watchful waiting represent the most common treatment options offered to men with clinically localized carcinoma of the prostate . The optimal treatment for these patients is often controversial, and selecting a treatment represents a tremendous challenge both for patients and for health care providers. The decision-making process would be more straightforward if the results were available from a trial comparing various quality-of-life and survival outcomes for men randomized to radical prostatectomy, radiation therapy, and watchful waiting and followed up for 15 years. Selecting Treatment for High-Risk, Localized Prostate Cancer : The Case for Radical Prostatectomy Herbert Lepor, MD, FACS Department of Urology, New York University School of Medicine, New York, NY The most common treatment options for men with clinically ...

prostate cancer The Instructional Innovations Lecture Series ?The Georgia Prostate Cancer Education Project: A Model for Cancer Education in Georgia ? Dabney Evans, MPH, CHES, Instructor Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University John Brunet, MLIS , Director of Multimedia Development & Distance Learning Technologies Applied Public Health, Rollins School of Public Health, Emory University Thursday, February 13, 2003 Sponsored by Centers for Disease Control and Prevention; The Rollins School of Public Health of Emory University The Emory University School of Medicine And The Nell Hodgson Woodruff School of Nursing of Emory University This month?s presentation is a presentation of a comprehensive statewide health message and professional training about prostate ...

FOR IMMEDIATE RELEASE Largest Prostate Cancer Prevention Trial Ever Opens for Business Toronto, ON (July 24, 2001) — Researchers at Sunnybrook & Women’s and Princess Margaret Hospital officially began accepting recruits today for North America’s largest prostate cancer prevention study that will examine the benefits of selenium and vitamin E. Partnering with the National Cancer Institute and hundreds of other sites across the continent, Princess Margaret and Sunnybrook & Women’s will help conduct the Selenium and Vitamin E Cancer Prevention Trial, or SELECT study, which will involve 400 sites in Canada, the United States and Puerto Rico. It will take up to 12 years to complete and involve over 32,000 men. "SELECT is the first study designed to look directly at the effects of vitamin E and selenium, both separately and together, in preventing prostate cancer ," said Dr. Neil ...

prostate cancer FAMILY HISTORY OF PROSTATE CANCER Men in the United States without any family history of prostate cancer have a one in eight chance of developing prostate cancer . Men that have one first degree relative (father or brother) with prostate cancer have twice the lifetime risk of contracting the disease (one out of four chance). Men with two affected first-degree relatives have five times the risk as men with out a family history (one out of two chance). Men with three affected first degree relatives are at eleven times greater risk of getting prostate cancer compared to men that have no family history. PROSTATE CANCER SCREENING The PSA level in the blood is very stable in healthy men without prostate cancer . PSA levels in men with cancer almost always tend to elevate. PSA blood test values in men without prostate cancer will generally be very stable ...

UCLA PROSTATE CANCER INDEX Short Form (UCLA-PCI-SF), including the RAND 12-Item Health Survey v2 (SF-12 v2) HEALTH-RELATED QUALITY OF LIFE SCORING INSTRUCTIONS © 1999 Mark S. Litwin, MD, MPH mlitwin@ucla.edu Page 2 Scoring Summary The UCLA Prostate Cancer Index was developed by researchers at UCLA and RAND to measure health-related quality of life (HRQOL) in patients treated for prostate cancer . It addresses general HRQOL and organ-targeted HRQOL. The instrument has been validated psychometrically in this population. Reliability and validity statistics for the instrument are included in reference 7. The Index contains three parts. This document explains the scoring rules for each of these parts. The components of the Index are: 1. RAND 12-Item Health Survey v2 (SF-12 v2) Items 1-7 ...

10468 10463 10453 10457 10471 10458 10451 10452 10460 10472 10456 10455 10454 10459 10474 10466 10464 10465 10469 10461 10462 10475 10473 10467 10470 Comparison of individual zip codes with expected incidence more than 100% above expected 50% to 100% above expected 15% to 49% above expected within 15% of expected 15% to 50% below expected more than 50% below expected very sparse data Prostate Cancer Incidence by ZIP Code Adjusted for Age and Race Bronx County 1994-1998

Clinical Application Notes, June 2001 1 Successful treatment of locally confined prostate cancer with the SeedNet™ system - Preliminary multicenter results Yan Moore, MD Paul Sofer, MD Galil Medical, Yokneam, Israel UPDATED: June 2001 Introduction Prostate cancer , most commonly diagnosed during the sixth decade of life, is the second most common malignancy found in men, and the second most common cause of cancer deaths in men after lung cancer (Landis 1998). Please see the American Cancer Society website which may be a reference for more recent information on statistics. Currently, a patient diagnosed with early stage prostate cancer is basically offered two options - Radical Prostatectomy [RP] and various types of Radiation Therapy [RT] (implanting internal radioactive seeds, external beam irradiation, or a combination ...

Access, Awareness, Outreach, and Advocacy: Mobile Prostate Cancer Screening as a Model for Reaching and Organizing Men Quentin Lockwood III, M.A., Jamie Bearse and Richard N. Atkins, M.D. In the United States, prostate cancer is the most commonly diagnosed non-skin cancer . 1 According to the American Cancer Society, approximately 180,000 men will be diagnosed with the disease and 32,000 men will lose their lives this year. 2 These numbers are comparable with those of breast cancer incidence and mortality in the United States. 3 Only about 7 percent of U.S. government cancer research dollars are spent on finding a cure for a disease that accounts for nearly 16 percent of all cancer cases. 4 Given these facts, the National Prostate Cancer Coalition (NPCC) developed a mobile prostate cancer ...

Status Appro ved Appro ved with Changes Ar t Director Creativ e Director Cop ywr iter Account Ex ecutiv e Client An Educational Service of the Canadian Prostate Health Council A PATIENT’S GUIDE PROSTATE CANCER AND DIET HSS ELI C04030E CPHC Pamphlet 5/14/04 12:38 PM Page 1 Station: blam Page 2 Prostate cancer is the most commonly diagnosed cancer in Canadian men. One out of 8 will develop prostate cancer during their lifetime. Prostate cancer may be curable if diagnosed early. Even when the disease is advanced, treatment may eradicate symptoms and improve survival. Medical evidence suggests that diet may influence the risk of developing prostate cancer as well as the progression of cancer in patients ...

PROSTATE CANCER : Surgery and radiation cause different complications. Researchers led by a team from the National Cancer Institute compared the side effects of treatments for localized prostate cancer in 1,591 men between the ages of 55 and 74. Two years after treatment, the 1,156 men who had surgery had more problems with urinary incontinence (9.6 percent vs. 3.5 percent) and impotence (79.6 percent vs. 61.5 percent) compared to those who had radiation. The 435 men who had radiation had more bowel problems such as diarrhea (37.2 percent vs. 20.9 percent). Ninety-two percent of all patients said they would choose the same treatment again. This is the first study to directly compare side effects of radiation vs. surgery for the treatment of localized prostate cancer in a diverse group of patients. The men were surveyed about side effects at six, 12 and 24 months after diagnosis. The characteristics ...

Summer, 2002 GWCCS Prostate Cancer Support Group & Internet Resource Guide Page 1 www.gwccs.org Greater Washington Coalition for Cancer Survivors (202) 364-6422 Prostate Cancer Support Groups SPONSOR GROUP/ DESCRIPTION MEETING DAY/TIME LOCATION CONTACT & PHONE STATE George Washington Medical Center “Us Too” 2nd Saturday 10:00 AM – Noon Call before coming GWU Medical School 23 rd and Eye Streets, NW Barbara Apseloff (202) 994-4907 or Don Hibbard (301) 277-0755 DC Georgetown University Hospital “US Too” Department of Urology 2 nd Tuesday 7:00-9:00 PM Gorman Auditorium Sharon Saquella (202) 687-4613 DC Providence Hospital “Man to Man” 3 rd Wednesday-Every Other ...

1 A MARINE’S PROSTATE CANCER JOURNAL By John Van Nortwick I am posting this journal that records my experiences with prostate cancer in the hope that it will help one or more of the Marines or other Vietnam Vets out there. While it may be preaching to the choir for many whom have already been thru this, I feel that if I can help just one of you who is facing the same situation I did, then it will be well worth the effort. The possible relationship between Vietnam service, Agent Orange, and prostate cancer makes it even more important to post this. The increasing number of deaths of so many Popasmoke members from cancer in the recent past only reinforces this more. I do not pretend to say that we did the right things or the wrong things, just stating the things we did. I use the term “we” and “us” because my wife, Sonja, who many of you know, was beside me every step of the ...